Q&A: GSK’s CEO Emma Walmsley on the new Trump administration, trust, AI and Chinanews2024-11-06T18:49:02+00:00November 6th, 2024|Endpoints News|
Baxter pulls IV products out of China to shift supply to the USnews2024-11-01T11:59:38+00:00November 1st, 2024|Endpoints News|
Gardasil demand in China sinks, and Merck expects the same next quarternews2024-10-31T17:33:18+00:00October 31st, 2024|Endpoints News|
AstraZeneca China exec probed by local authoritiesnews2024-10-30T15:15:13+00:00October 30th, 2024|Endpoints News|
WuXi AppTec is still signing on new clients despite Biosecure threatnews2024-10-28T18:26:16+00:00October 28th, 2024|Endpoints News|
BeiGene executive reportedly under investigation in Chinanews2024-10-28T16:07:50+00:00October 28th, 2024|Endpoints News|
Growing Cannabis and Opium Poppies May Be Key to U.S. Supply Chainsnews2024-10-07T16:29:21+00:00October 7th, 2024|The New York Times|
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countriesnews2024-10-02T23:12:20+00:00October 2nd, 2024|The New York Times|
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugsnews2024-04-15T19:47:14+00:00April 15th, 2024|The New York Times|
Israel-Hamas Truce Appears to Enter Another Day, and Morenews2023-11-28T11:02:10+00:00November 28th, 2023|The New York Times|
